Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine-rich and transmembrane domain-containing protein 1 (SERTM1, encoded by the SERTM1 gene, also known as C13orf36) is a putative membrane protein in humans, predicted to be rich in serine residues and to possess transmembrane regions[3][8][9]. Human SERTM1 is classified as a protein-coding gene (Gene ID: 400120, Chromosome 13)[3][8]. Its protein product’s function is not experimentally validated, but it is predicted to localize to cellular membranes[3][9]. SERTM1 is expressed in multiple human tissues, including the brain, but no tissue-specific functional role or linkage to specific physiological or pathophysiological processes has been established[5][6]. There are no reports of SERTM1 as a drug target, disease biomarker, or involvement in signaling pathways, enzyme functions, transport activity, or receptor-like activity based on current genomic and proteomic database annotations[3][8][9]. The gene is sometimes listed as C13orf36 in older literature, reflecting its chromosomal location before formal naming[3]. SERTM1 has been used in transcriptomic profiling as a molecular marker in certain neuronal subtypes (e.g., mitral cell subtypes of the mouse olfactory bulb), but no direct functional role has been assigned[2]. No mechanisms of action, interacting drugs, disease roles, or safety profile are available for this protein at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine-rich and transmembrane domain-containing protein 1 (SERTM1).